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NMR spectroscopy and X-ray crystallography are two premium methods for determining the atomic structures of 
macro-biomolecular complexes. Each method has unique strengths and weaknesses. While the two techniques are highly com-
plementary, they have generally been used separately to address the structure and functions of biomolecular complexes. In this 
review, we emphasize that the combination of NMR spectroscopy and X-ray crystallography offers unique power for elucidat-
ing the structures of complicated protein assemblies. We demonstrate, using several recent examples from our own laboratory, 
that the exquisite sensitivity of NMR spectroscopy in detecting the conformational properties of individual atoms in proteins 
and their complexes, without any prior knowledge of conformation, is highly valuable for obtaining the high quality crystals 
necessary for structure determination by X-ray crystallography. Thus NMR spectroscopy, in addition to answering many 
unique structural biology questions that can be addressed specifically by that technique, can be exceedingly powerful in mod-
ern structural biology when combined with other techniques including X-ray crystallography and cryo-electron microscopy. 
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Since the first protein structure was determined in the mid-
dle of last century, structural biology has had a critical role 
in driving the development of modern biology, chiefly by 
providing atomic level resolution of individual as well as 
complexed forms of biological molecules. X-ray crystal-
lography and NMR spectroscopy are the two main methods 
that have been used for deriving high resolution atomic pic-
tures of biomolecules, though cryo-electron microscopy is 
gaining momentum in this research direction. X-ray crys-
tallography was first developed to determine biomolecular 
structures based on X-ray diffraction of single crystals [1,2] 
(Figure 1B). However, many biomolecules are difficult to 
crystallize, or even cannot be crystallized, because of fac-
tors such as intrinsically disordered regions and the hetero-
geneous conformational properties of samples. Conse-
quently, the most critical step for X-ray-based structure de-
termination has been and will continue to be obtaining high 
quality crystals of samples of interest. By contrast, NMR 
spectroscopy can determine biomolecular structures in solu-
tion or in their solid state without the need to obtain crystals 
[3–8]. NMR spectroscopy has been particularly useful for 
defining the conformation of proteins with low molecular 
weights as well as proteins with large intrinsically disor-
dered regions [4,5,9–11]. Nonetheless, inherent technical 
deficiencies as well as practical limitations of NMR spec-
troscopy limit the wider applications of the technique to  
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Figure 1  NMR spectroscopy and X-ray crystallography are two premium methods of structural biology. A, A typical 1H-15N HSQC spectrum of a protein. 
One cross peak in the spectrum (indicated by the arrow) represents one amino acid in the protein. B, An example X-ray diffraction map of a protein. The 
diffraction data can be converted into the electron density map of each amino acid in the protein. C, Understanding of the functions of biomolecules requires 
various information including their 3-D structures, detailed interactions, as well as dynamic properties. NMR spectroscopy can be used to determine the 
structures, dissect molecular interactions, and investigate the dynamics of proteins. X-ray crystallography is particularly powerful for determination of the  
atomic structures of highly complicated biological systems. 
determine high quality structures of proteins with large mo-
lecular weights. Thus, NMR spectroscopy and X-ray crys-
tallography are generally regarded as complementary tech-
niques for the structure determination of biomolecules 
[4,12,13]. 
Compared with X-ray crystallography, NMR spectros-
copy has unique features. The capability of NMR spectros-
copy for detecting individual atoms in terms of chemical 
shifts, coupled with the exquisite sensitivity of chemical 
shifts of atoms to their conformational environment, makes 
it the most powerful of all spectroscopic techniques. From 
the structural biology viewpoint, NMR spectroscopy is the 
only method that allows direct monitoring of the conforma-
tional properties of a protein or its complex at the individual 
amino acid level (e.g. via recording 1H, 15N and 13C chemi-
cal shifts; Figure 1A), without any prior conformational 
knowledge of the protein. In addition, NMR spectroscopy 
allows monitoring of conformational changes of a protein or 
its complex upon the introduction of changes to the sample 
condition. These two features of NMR spectroscopy render 
the technology exceedingly powerful when compared with 
X-ray crystallography, as crystallization processes are 
largely based on trial-and-error methods. Finally, recent 
developments of NMR technology (cryogenic detection 
system combined with ultra-high magnetic field) have es-
sentially removed the major limitation of the technique 
which is its intrinsically low sensitivity. It is now possible 
to record a good quality NMR spectrum (e.g. 1H-15N HSQC 
spectrum) of a protein sample at a concentration as low as 
10 μmol L−1 within a few hours. Moreover, it should be 
emphasized that there is essentially no molecular size limit 
for recording chemical shift information of proteins or their 
complexes by NMR spectroscopy.  
NMR spectroscopy has been highly successful in the de-
termination of biomolecular structures [3,14–16]. As the 
chemical shift of each atom is highly sensitive to changes 
induced by environmental perturbations such as target 
binding, NMR spectroscopy has also been used to investi-
gate biomolecular interactions since its first applications in 
biology [17–19]. Furthermore, NMR spectroscopy is 
uniquely suited for, and has been exceedingly powerful in 
investigating dynamic properties of biomolecules [20–24]. 
The three-dimensional structure, interaction with its binding 
partners, and dynamic properties together provide a more 
complete understanding of cellular functions of a bio-
molecule (Figure 1C). NMR spectroscopy is probably the 
only technique that alone can provide atomic details in all 
three of these areas, and thus is recognized as an indispen-
sable method in modern structural biology [25]. Because of 
space limitations, we limit this review to the combination of 
NMR spectroscopy and X-ray crystallography for the study 
of the structure and function of proteins and protein com-
plex assemblies.  
NMR spectroscopy and X-ray crystallography are highly  
complementary in terms of structural determinations, and in  
the past have been generally used separately to investigate  
biomolecular complexes. Recently, NMR spectroscopy has  
been frequently combined with X-ray crystallography to  
dissect the structures of complicated biomolecular com- 
plexes. The sensitivity and ultra-high resolution of NMR  
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chemical shifts make NMR spectroscopy a unique tool for  
investigating conformational properties of biomolecules at  
the atomic level without any prior structural information  
(Figure 1A). More importantly, the quality of the NMR  
spectrum (i.e. peak dispersion pattern, line-widths, and ho- 
mogeneity) is directly related to the conformational prop- 
erty of the sample being investigated. Such NMR-derived  
information can be very valuable for obtaining high quality  
crystals of the molecules of interest. NMR spectroscopy can  
be used for sample conditioning, and tracing changes in  
protein behavior upon the addition of additives, and thus  
nicely fills the gap in the “all-or-nothing” mode of crystal- 
lization screening by X-ray crystallography. An increasing  
number of successful examples have demonstrated the  
power of NMR spectroscopy when combined with X-ray  
crystallography, in answering fundamental biological ques- 
tions by providing high resolution structures of complicated  
protein assemblies [26–29].  
In this review, we use several recent examples from our  
own laboratory to illustrate the power of the combined use  
of NMR spectroscopy and X-ray crystallography in solving  
structures of protein complexes involved in neuronal sig- 
naling and cell polarity. We focus on how we integrate in- 
formation derived from NMR spectroscopy, biochemistry  
and crystallization screening, in an iterative manner, to ob- 
tain high quality samples for solving high resolution struc- 
tures. However, we do not dwell on the biological details of  
each system described here, as readers can refer to the rele- 
vant papers for details. We hope that the review will pro- 
vide helpful information on how to combine NMR spec- 
troscopy and X-ray crystallography for structural studies of  
complicated biomolecular systems. We also wish to en- 
courage more scientists to actively participate in using these  
two premium structural biology methods, in view of the  
major equipment build-ups under the “National Protein  
Science Research Infrastructure” scheme in China.  
1  L27 domain-mediated supra-molecular com-
plex assembly dissected by NMR spectroscopy 
L27 domain, originally indentified in scaffold proteins  
Lin-2 and Lin-7, is a novel protein interaction module that  
mediates the assembly of supra-molecular scaffold protein  
complexes for membrane trafficking, polarized protein dis- 
tributions, and cell-cell contacts [30]. To elucidate the  
structural basis of L27 domain-mediated supra-molecular  
assembly, we selected one pair of L27 domain complexes  
formed between SAP97 L27 (L27SAP97) and mLIN2 L27N  
(L27NmLIN2) to begin our study (Figure 2A). As NMR spec- 
troscopy has always been used to monitor sample conditions  
and to check preliminary structural information (e.g. the  
proper folding indicated by specific peak dispersion pat- 
terns), we purified the isolated L27SAP97 and L27NmLIN2 and  
recorded their NMR spectra. The 1H-15N HSQC spectra of  
the isolated L27 domains demonstrated that neither of them 
forms a defined conformation, as indicated by severe peak 
broadening or the narrowly dispersed peaks that are indica-
tive of unfolded proteins (Figures 2C1 and C2). Interest-
ingly, when we mixed 15N-labelled L27SAP97 with unlabelled 
L27NmLIN2 or vice versa, sharp and well-dispersed peaks 
appeared, indicating that the L27 domain complex (con-
taining two related L27 domains) forms a more compact 
structural unit (Figures 2C3 and C4). Thus NMR spectros-
copy was used to detect the specific binding of a pair of 
cognate L27 domains in solution, and to monitor conforma-
tional transitions of the L27 domains from the unfolded or 
partially unfolded states to the much better folded state 
upon complex formation (Figures 2C1 and C3, and Figures 
2C2 and C4). To aid structural determination by the 
NMR-based method, we co-expressed the two L27 domains. 
Although the HSQC spectrum of the co-expressed sample 
confirmed the well-defined structural assembly of the L27 
domain complex, the spectra were still not optimal for NMR 
structure determination (i.e. missing peaks, and very low 
intensities of some peaks; Figure 2C5). 
To determine the complex structure we next screened a 
large number of sample conditions, and each step of the 
changes was monitored by recording an 1H-15N HSQC 
spectrum [31]. To ensure 1:1 stoichiometry of each domain 
in the complex, we fused the two L27 domains into a single 
chain using a flexible linker. The NMR spectrum of the 
fused sample was of excellent quality (well-dispersed peaks 
with sharp line-width) and thus suitable for NMR-based 
structural determination (Figure 2C6). The solution struc-
ture of L27SAP97/L27NmLIN2 complex was determined by 
conventional multidimensional NMR spectroscopy. The 
structure revealed that the cognate L27 domain complex 
forms a tetramer in solution. Each L27 domain contains 
three helices; the first two helices (αA and αB) of each do-
main form a dimeric helical bundle at two opposite sites, 
and the last helix (αC) forms the central helical bundle to 
assemble two dimers into a symmetric tetramer (Figure 2B). 
Since each L27 domain complex is a tetramer, the cognate 
complexes between the “type A” orphan L27 domain and 
the “type B” tandem L27 domains can further assemble into 
a multimer that we termed supra-scaffold assemblies for 
very large signaling complex assembly in polarized cells 
[31]. The story above illustrates the iterative use of NMR 
spectroscopy in sample conditioning for NMR-based struc-
tural determination. We now switch to the combined use of 
NMR spectroscopy and X-ray crystallography in dissecting 
the assembly mechanism of protein complexes. 
2  Myosin VI CBD/Dab2 complex structure de-
termination: NMR leads the way 
Myosin VI is the only known myosin motor that transports 
cargoes towards the minus end of actin-filaments [32,33].  
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Figure 2  Dissection of the L27 domain-mediated supra-molecular complex assembly by NMR spectroscopy. A, The domain organization of CASK/LIN2 
and SAP97. CASK contains the two “Type A” L27 domains arranged in tandem, namely L27N and L27C; SAP97 contains a single “Type B” L27 domain.  
B, A ribbon diagram representation of the tetrameric L27SAP97/L27NmLIN2 complex determined by NMR spectroscopy. L27SAP97 and L27NmLIN2 are colored 
orange and green, respectively. C, 1H-15N HSQC spectra of the isolated L27SAP97 (C1), the isolated L27NmLIN2 (C2), the L27SAP97/L27NmLIN2 complex prepared 
by mixing the two domains (C3-C4), the L27SAP97/L27NmLIN2 complex prepared by co-expression of the domains (C5), and the single-chain-fused  
L27SAP97/L27NmLIN2 complex with a (GS)n linker (C6). 
Myosin VI contains an N-terminal motor domain, a short 
neck region and a signal α-helix (SAH) domain in the mid-
dle, and a C-terminal cargo-binding domain (CBD) (Figure 
3A). Myosin VI has been reported to exist both as a mono-
mer for anchoring and a dimer for transportation. The 
dimerization of myosin VI absolutely requires both the  
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Figure 3  Structure determination of myosin VI CBD by NMR spectroscopy. A, Domain organizations of myosin VI and Dab2. Myosin VI contains an 
N-terminal motor domain, a short neck and a SAH domain in the middle, and a C-terminal cargo-binding domain (CDB). Dab2 contains an N-terminal PTB 
domain and a C-terminal myosin VI interaction region (MIR). The interaction between myosin VI and Dab2 is mediated by the CBD and the MIR. B, A 
ribbon diagram representation of myosin VI CBD in its apo-form. C, 1H-15N HSQC spectra of 0.2 mmol L−1 wild type (WT) CBD (C1), 1.0 mmol L−1 WT  
CBD (C2), 1.0 mmol L−1 WT CBD with 0.5% CHAPS (C3), and 1.0 mmol L−1 “L2K”-CBD (C4). 
CBD and its cargo-binding [33]. To determine the structural 
basis of myosin VI dimerization, we first purified the CBD 
and used NMR spectroscopy to check the sample quality 
and the conformational property of the domain. The domain 
showed well-dispersed 1H-15N HSQC peaks at low sample 
concentrations (<0.2 mmol L−1), indicating that it might be 
amenable for NMR-based structure determination (Figure 
3C1). Unfortunately, the quality of the NMR spectra dete-
riorated continuously upon increase of the sample concen-
tration (i.e. a large set of peaks severely broadened at high 
concentrations; Figure 3C2). The deterioration of the NMR 
spectra was most likely the result of non-specific aggrega-
tion of the domain at high concentrations. To overcome the 
aggregation problem we used the NMR-based sample con-
dition screening, by systematically testing various additives 
in the sample buffer. We discovered that addition of a small 
amount of CHAPS, a non-ionic detergent, dramatically im-
proved the spectral quality of the domain at a protein con-
centration as high as ~1.0 mmol L−1 (Figure 3C3). This 
finding suggested that hydrophobic interaction is an impor-
tant factor causing the non-specific, concentration-depend-     
ent aggregation of myosin VI CBD. We next assigned the 
chemical shift of the domain in the presence of CHAPS, and 
obtained the rough topology of the domain by NMR 
spectroscopy. We searched for point mutations of myosin 
VI CBD that can disrupt the non-specific aggregation but do 
not alter the conformation of the domain. The site of muta-
tion was based on the rough topology of the domain, and the 
overall folding of the mutants was assessed by comparing 
their HSQC spectra with that of the WT CBD at low con-
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centration (Figure 3C1). One of the point mutations (L2K 
mutation with Leu1209 substituted with Lys) showed an 
excellent spectrum at very high concentration of the CBD, 
and the spectrum of the mutant was essentially the same as 
that of WT CBD (Figure 3C4). Using this “L2K”-mutant, 
we determined the solution structure of myosin VI CBD by 
NMR spectroscopy (Figure 3B). The structure revealed that 
myosin VI CBD forms a monomer and adopts a novel fold-
ing with a central β-sheet formed by four strands (βA-βD) 
as the core of the CBD and both sides of the β-sheet are 
capped with α-helices (Figure 3B). Intriguingly, all the 
helices are packed with the upper half of the CBD β-sheet. 
The lower half of the β-sheet, which is hydrophobic and 
functions as the binding site for the Dab2 cargo, is com-
pletely exposed to the solvent (Figure 3B). The concentra-
tion-dependent aggregation of the WT CBD also occurs via 
the exposed hydrophobic site, as Leu1209 is at the center of 
this hydrophobic surface [27].  
We selected one cargo adaptor Dab2 for investigating 
motor/cargo interactions (Figure 3A). Dab2 is a small 
adaptor for clathrin-mediated endocytic vesicles. Dab2 con-
tains an N-terminal PTB domain for binding to cell surface 
receptors and a C-terminal conserved region (called “MIR” 
for myosin VI interacting region) for binding to myosin VI 
(Figure 3A). The MIR was predicted to contain two helices 
(Figure 4A), and previous studies showed that the first helix  
 
 
Figure 4  Structure determination of the myosin VI CBD/Dab2 MIR complex. A, The mapping of the interaction interface between myosin VI CBD and 
Dab2 MIR by NMR spectroscopy. The two conserved helices of Dab2 MIR bind to two exposed hydrophobic surfaces of myosin VI CBD. The first MIR 
helix binds to “Site I” and the second helix binds to “Site II” as indicated by red arrows. B, 1H-15N HSQC spectra of the single-chain-fused myosin VI 
CBD/Dab2 MIR complex (with a (GS)n linker and a protease cutting site), before (B1) and after (B2) cleavage. C, A ribbon diagram representation of the myosin  
VI CBD/Dab2 MIR complex showing MIR-induced dimerization of the CBD. The CBD and two MIRs are colored pink, green and orange, respectively. 
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(αA’) was sufficient for its binding to myosin VI [34]. We 
verified the binding between myosin VI and Dab2 αA’; the 
two fragments bind with reasonably strong binding affinity 
(Kd ~0.4 μmol L−1; [27]). We tried to determine the com-
plex structure either by NMR spectroscopy or by X-ray 
crystallography. Under numerous conditions tested, the 
quality of the NMR spectra of the complex was insufficient 
for structure determination. Extensive trials of crystalliza-
tion of the complex also failed. We decided to revisit the 
interaction between myosin VI CBD and Dab2 by carefully 
monitoring chemical shift changes in CBD upon binding to 
various versions of Dab2 proteins. We noticed that addition 
of the Dab2 fragment containing the first helix induced 
large chemical shift changes in myosin CBD, and these 
chemical shift changes were mapped to the site I pocket of 
the domain (Figure 4A). Unexpectedly, addition of an ex-
tended Dab2 fragment, which contains the second helix, 
caused further chemical shift changes in addition to the 
residues at site I, and the second site was termed the site II 
cargo binding pocket of myosin CBD (Figure 4A). The 
above observation revealed that the myosin VI binding re-
gion of Dab2 contains two helices instead of the previously 
assumed single helix [27]. 
Once the complete myosin VI-binding region of Dab2 
was mapped, we again used NMR spectroscopy to search 
for the best construct/sample conditions for determining the 
complex structure. We tried various methods to prepare the 
myosin VI/Dab2 complex including co-purification, co-ex-    
pression, and covalent fusion of myosin VI CBD and Dab2 
MIR. Again, to ensure the stoichiometry of the CBD/Dab2 
complex we fused the Dab2 MIR peptide to the C-terminus 
of the CBD with a linker that can be cleaved by a specific 
protease. The NMR spectra of the fused CBD-Dab2 protein 
prior to being cleaved by the protease were poor (Figure 
4B1); after protease cleavage, however, the spectra were 
excellent (Figure 4B2). The excellent conformational ho-
mogeneity and high stability of the complex sample 
prompted us to screen for crystals of the complex. At the 
first trial with only 196 conditions using the sample pre-
pared as described above, we obtained high quality crystals 
of the complex (diffracted to 2.25 Å resolution in an 
in-house diffractor) [27]. The crystal structure showed that 
the CBD/Dab2 complex forms a dimer-of-dimers assembly 
which is induced by the binding of the two helices in the 
Dab2 MIR (Figure 4C) [27]. The complex structure reveals 
that myosin VI (and perhaps other myosins as well) under-
goes a cargo binding-mediated dimerization [27]. 
In the course of studying the myosin VI CBD/Dab2 
complex, NMR spectroscopy was extensively used to elu-
cidate the interactions leading to the aggregation of the iso-
lated CBD. NMR was also used to find the optimal sample 
condition for both NMR- and X-ray-based structure deter-
minations. Importantly, based on its great sensitivity in de-
tecting binding-induced structural changes, NMR was used 
to discover the previously missed critical component in 
Dab2 that is necessary for the formation of the functional 
myosin VI/Dab2 complex. We emphasize that the utiliza-
tion of NMR spectroscopy in sample condition screening 
can greatly enhance crystallization success rates. We almost 
never needed to set up a large number of crystal screening 
conditions to obtain high quality crystals in systems when 
NMR spectroscopy provided favorable conformational 
knowledge.  
3  Harmonin NPDZ1/Sans SAM-PBM complex 
structure determination: it could not have been 
done without the assistance of NMR spectros-
copy 
Harmonin (USH1C) is a central scaffold protein involved in 
the organization of the USH1 protein network, which is 
essential to establish and maintain hair cell stereocilia 
[35–37]. Harmonin contains an N-terminal domain followed 
by two PDZ domains, a central coiled-coil region and a 
PDZ domain at the C-terminus (Figure 5A). Sans (USH1G) 
is another scaffold protein among the USH1 proteins [38]. 
Sans contains four N-terminal ankyrin repeats, a central 
region, and a C-terminal SAM domain. The extreme 
C-terminal tail also possesses a classic PDZ binding motif 
(PBM) (Figure 5A). It was reported that the first PDZ domain 
of Harmonin binds to the SAM domain from Sans [39], but 
the structural basis of such noncanonical PDZ/target inter-
actions was unclear.  
To clarify the molecular basis of the Harmonin PDZ/    
Sans SAM interaction, we sought to determine the complex 
structure. The N-terminal domain together with the first 
PDZ domain of Harmonin forms an NPDZ1 supramodule, 
which was used for further characterization of its interac-
tions with Sans [28]. The high affinity and stoichiometric 
interaction between Harmonin and Sans was mapped to the 
N-terminal domain and PDZ1 supramodule (NPDZ1) of 
Harmonin and the SAM domain containing PBM of Sans 
(Figure 5A). In view of the high molecular weight of the 
complex, we decided to solve the NPDZ1/SAM-PBM com-
plex structure by X-ray crystallography. The complex pre-
pared from the wild type Harmonin NPDZ1 and Sans 
SAM-PBM formed large crystals but diffracted poorly (to 
only 3.6 Å resolution). Extensive trials for new crystalliza-
tion conditions failed to improve the quality of the complex 
crystals. We again resorted to NMR spectroscopy for an-
swers. To simplify the experimental system, we screened 
the conditions of NPDZ1 and SAM-PBM separately. In the 
NPDZ1 sample condition screening, to increase the protein 
expression and solubility we fused the Sans PBM to the 
C-terminus of the NPDZ1. The poor NMR spectrum of the 
wild type NPDZ1-Sans-PBM indicated that the protein is 
prone to non-specific aggregation (Figure 5C). We discov-
ered by screening for various additives in the sample buffer 
that inclusion of high salt could markedly improve the spec- 
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Figure 5  Structure determination of the Harmonin NPDZ1/Sans SAM-PBM complex. A, Domain organizations of Harmonin and Sans. Harmonin contains 
an N-terminal domain, three PDZ domains and a coiled-coil (CC1) domain in the middle. Sans contains an N-terminal ankyrin repeats (ANK) domain, a 
central domain (cen), and a C-terminal SAM domain with a PDZ-binding motif (PBM). B, A ribbon diagram representation of the Harmonin NPDZ1/Sans 
SAM-PBM complex. The N-domain, PDZ1, SAM-PBM and the mini domain are colored green, orange, blue and pink, respectively. The two point muta-
tions identified to facilitate complex crystallization are indicated with dotted circles. C–E, 1H-15N HSQC spectra of NPDZ1-Sans-PBM with 100 mmol L−1 
NaCl (C), NPDZ1-Sans-PBM with 700 mmol L−1 NaCl (D), and NPDZ1(K157E)-Sans-PBM with 100 mmol L−1 NaCl (E). F, An overlay plot of the 1H-15N  
HSQC spectra of SAM-PBM and SAM-PBM (K437E). 
tral quality of the fused protein (Figure 5D), indicating that 
the concentration-dependent aggregation is mediated mainly 
by charge-charge interactions. Aided by extensive amino 
acid sequence analysis and modeling, we found that substi-
tution of Lys157 by Glu eliminated the nonspecific aggre-
gation of NPDZ1, as the NMR spectrum of the mutant in 
low salt buffer was highly homogenous (Figure 5E). The 
complex prepared using the K157E-NPDZ1 mutant and the 
wild-type SAM-PBM readily formed crystals that were dif-
fracted to 3.2 Å resolution (vs 3.6 Å for the WT NPDZ1). 
Encouraged by this positive result, we tried to improve the 
sample property of SAM-PBM, as the wild type protein 
tends to aggregate and form various homo-oligomers in 
solution (Figure 5F). Again using NMR spectroscopy-based 
sample condition screening, we found that mutation of 
Lys437 on the SAM domain of Sans with Glu significantly 
improved the conformational homogeneity of SAM-PBM 
(Figure 5F). To our delight, the crystals obtained using the 
K157E-NPDZ1/K437E-SAM-PBM complex were diffracted 
to 2.3 Å. The structure of the complex was successfully de-
termined using molecular replacement methods (Figure 5B). 
The structure shows that the Harmonin NPDZ1 indeed 
forms a supramodule with its N-domain and PDZ1 inte-
grated by a mini-domain (a 25-residue extension C-terminal 
to PDZ1). Unexpectedly, the Sans SAM domain packs ex-
tensively with the αB and βE of PDZ1, forming a novel 
interaction mode for PDZ domains (Figure 5B). Conse-
quently, the NPDZ1/SAM-PBM complex structure reveals a 
completely new PDZ domain-mediated protein/protein in-
teraction mode [28]. 
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In the NPDZ1/SAM-PBM complex study, NMR spec-
troscopy was extensively incorporated into X-ray crystal-
lography at various stages of the project (e.g. for monitoring 
sample quality, identifying residues responsible for non-     
specific aggregation, and discovering specific mutations for 
preparing high diffraction quality crystals) [28]. It should be 
emphasized here that we have taken great care in designing 
point mutations of various proteins for structural studies by 
minimizing possible structural changes introduced by muta-
tions. Again, NMR spectroscopy has played a crucial role in 
such exercises, as the technique allows us to monitor 
chemical shift changes introduced by mutations. For exam-
ple, the two mutations used in determining the Har-
monin/San complex (K157E of Harmonin NPDZ1 and 
K473E of Sans SAM-PBM) are both on the solvent exposed 
surface of each protein and away from the interface of the 
complex (Figure 5B).  
4  Uncovering of the closed conformation of 
lipidated Ykt6: NMR spectroscopy provides a 
direction for crystallography 
Ykt6 is an evolutionarily conserved SNARE protein, essen-
tial for vesicle membrane fusion at the Golgi, vacuoles and 
endosomes [40–43]. Ykt6 is composed of an N-terminal 
longin domain followed by a SNARE core, and a 
C-terminal double lipidation “CCAIM”-motif (Figure 6A). 
Biochemistry and cell biology studies of Ykt6 have shown 
that it exists in both membrane-bound and soluble cytosolic 
forms, which are controlled by lipidations (i.e. the farnesy-
lation and the palmitoylation) [42–45]. However, the mo-
lecular basis of lipidation-mediated conformational regula-
tion of Ykt6 was unclear, as the unlipidated full length Ykt6 
is conformationally heterogeneous [44], and farnesylated 
Ykt6 could not be crystallized [46]. To determine the struc-
tural basis of lipidation-mediated Ykt6 membrane/cytosol 
cycling, we set out to study the interactions between lipids 
and Ykt6 using NMR spectroscopy.  
Because it was suggested that the longin domain of yeast 
Ykt6 binds to palmitoyl-CoA (Pal-CoA), we tested for po-
tential direct interactions between the Ykt6 longin domain 
and Pal-CoA using NMR spectroscopy. However, we could 
not detect any interactions between the Ykt6 longin domain 
and Pal-CoA (<40 μmol L−1 to avoid micelle formation) in 
our NMR-based assay. We screened several additional lipids 
for potential binding to the Ykt6 longin domain, and found 
that DPC (dodecylphosphocholine, with critical micelle 
concentration ~1.4 mmol L−1) binds weakly to Ykt6 longin 
domain (Figure 6B) [29]. To further investigate the interac-
tion with DPC, we next tested the binding of DPC to the full 
length of Ykt6 (including both the longin domain and the 
SNARE core). 
To our surprise, the addition of stoichiometric amounts 
of DPC induced large chemical shift changes for many 
residues in Ykt6 (Figure 6C, with Kd~60 μmol L−1 from the 
DPC titration), revealing that the full-length Ykt6 binds to 
DPC with much higher affinity than does the longin domain 
alone. The HSQC spectrum of the full-length Ykt6 in the 
absence of DPC (Figure 6D, blue peaks) showed that for a 
number of residues each backbone amide displayed several 
peaks, indicating that the protein exists in multiple confor-
mations exchanging at slow-to-intermediate timescales. The 
high sensitivity and resolution of NMR chemical shifts al-
lowed us to observe that one of these conformations coin-
cides with the fully open structure, as the amide peaks of 
this state overlap well with the corresponding amide peaks 
of the longin domain of the protein (Figure 6D, yellow 
peaks). Another conformation matches with the structure of 
the protein saturated with DPC (i.e. the fully closed con-
formation; Figure 6D, pink peaks). The rest of the confor-
mations of Ykt6 are between the fully open and completely 
closed state of the protein. This NMR-based study allowed 
us to conclude that the unlipidated full-length Ykt6 is highly 
dynamic, with conformations ranging from the fully open to 
the completely closed states interconverting in solution. 
The excellent NMR spectrum of Ykt6 in the presence of 
stoichiometric ratios of DPC indicates that under these con-
ditions, the protein adopts a stable and monodisperse con-
formation. Guided by this information, we succeeded in 
obtaining high quality Ykt6 crystals by simply mixing the 
protein sample in the presence of ~1 mmol L−1 DPC with 
ammonium sulfate. The structure of the full-length Ykt6 in 
the complex with DPC was solved at 2.4 Å resolution (Fig-
ure 6E) [29]. The structure of Ykt6/DPC complex reveals 
that the full length Ykt6 indeed adopts a fully closed con-
formation with a compact globular shape, i.e. the entire 
SNARE core wraps around the well-defined longin domain 
(Figure 6E). We further showed, with the aid of cell biology 
data and molecular dynamics simulations, that the Ykt6/DPC 
complex structure faithfully represents the structure of the 
farnesylated Ykt6 [29]. The Ykt6/DPC complex also shows 
that the farnesyl group in Ykt6 functions both as a classical 
membrane localization signal as well as a direct activity 
regulator. 
In the Ykt6/DPC complex study, NMR spectroscopy was 
instrumental in our discovery that DPC binds to Ykt6 in a 
stoichiometric manner. In addition, NMR was again shown 
to be exceedingly powerful in detecting conformational dy-
namics and assigning each sub-state among the conforma-
tional ensembles [29]. The examples demonstrate the power 
of NMR spectroscopy in elucidating structure-function rela-
tionships of complicated biological systems.  
5  Concluding remarks 
As a premium method for structural biology with its own 
unique features, NMR spectroscopy is highly advantageous 
to analyze complex biomolecular assemblies, characterize  




Figure 6  Lipidation-induced conformational switch of the Ykt6 SNARE. (A) Domain organization of Ykt6. Ykt6 contains an N-terminal longin domain 
and a SNARE core, and a C-terminal “CCAIM” lipidation motif. (B) An overlay plot of the selected region of the 1H-15N HSQC spectra of Ykt6N 
(N-terminal longin domain) and Ykt6N saturated with DPC. (C) An overlay plot of the 1H-15N HSQC spectra of a series of the titration points with different 
molar ratios of Ykt6ΔC (containing the login domain and the SNARE core without the “CCAIM” motif) to DPC. (D) An overlay plot of selected regions of 
the 1H-15N HSQC spectra of Ykt6N (colored yellow), Ykt6ΔC (colored blue) and Ykt6ΔC saturated with DPC (colored pink). (E) A ribbon diagram repre-
sentation of the Ykt6/DPC complex. The entire SNARE core (colored purple) is divided into several fragments (αD-αG and βF) and tightly wraps around 
the longin domain (colored green). The farnesyl group (in surface representation and colored orange) is modeled into the DPC binding pocket and locks Ykt6  
in a closed conformation. 
 
protein/protein or protein/ligand interactions, monitor con-
formational status and sample quality of proteins, and identify 
suitable sample conditions for high resolution structure de-
termination by both NMR spectroscopy and X-ray crystal-
lography. The examples discussed in this review touched on 
only a small proportion of the research that can benefit by 
combining NMR spectroscopy with other biophysical tech-
niques (X-ray crystallography in particular). Nonetheless, 
these examples strongly support our contention that the 
combination of NMR spectroscopy with other mainstream 
methods such as X-ray crystallography and cryo-electron 
microscopy can accelerate the process of discovery and 
broaden research horizons in modern structural biology.  
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